NRT (New Radiomedicine Technology Co., Ltd.) is a global radiopharmaceutical innovator, founded in 2016 and headquartered in Chengdu, with operations in San Diego and Melbourne. With 350+ specialists, NRT delivers end-to-end solutions from isotope production to drug commercialization. Our portfolio spans isotopes such as Ac-225, Lu-177, and Cu-64, proprietary platforms including iCleave™ linkers and TareSphere™ Y-90 microspheres, and FDA-cleared IND candidates for solid tumor diagnosis and therapy. NRT is committed to becoming a global leader in nuclear medicine technology.

NRT MedTech, Inc.

Org chart

Teams

Offices